Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study-Reference-Cited by-同舟云学术

Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study

Published:2018-05-31 Issue:8 Volume:96 Page:e933-e941
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Feltgen Nicolas¹^ORCID,Hattenbach Lars-Olof²,Bertelmann Thomas¹^ORCID,Callizo Josep¹,Rehak Matus³,Wolf Armin⁴,Berk Hüsnü⁵,Eter Nicole⁶,Lang Gabriele E.⁷,Pielen Amelie⁸,Schmitz-Valckenberg Steffen⁹,Quiering Claudia¹⁰,Rose Uwe¹⁰,Hoerauf Hans¹,

Affiliation:

1. Georg-August-University Goettingen; University Eye Hospital; Goettingen Germany

2. Department for Ophthalmology; Ludwigshafen Hospital; Ludwigshafen Germany

3. Eye Hospital; University Hospital Leipzig; Leipzig Germany

4. Department of Ophthalmology; Ludwig-Maximilians-University; Munich Germany

5. Department of Ophthalmology; St. Elisabeth-Hospital; Koeln-Hohenlind Germany

6. Department of Ophthalmology; University of Muenster Medical Center; Muenster Germany

7. University Eye Hospital Ulm; Ulm Germany

8. Department for Ophthalmology; University Hospital of Freiburg; Freiburg Germany

9. University of Bonn; University Eye Hospital; Bonn Germany

10. Novartis Pharma GmbH; Nuremberg Germany

Funder

Novartis Pharma

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13770/fullpdf

Reference20 articles.

1. Allergan 2016 Safety and efficacy study of Ozurdex ® compared to Lucentis ® in patients with branch retinal vein occlusion

2. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex(R)) for retinal vein occlusion;Bandello;Ophthalmic Res,2015

3. Optimal treatment of retinal vein occlusion: Canadian expert consensus;Berger;Ophthalmologica,2015

4. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study;Brown;Ophthalmology,2011

5. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study;Campochiaro;Ophthalmology,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial;International Ophthalmology;2024-06-24

2. Anatomical and Functional Results of Early or Late Switching from Anti-VEGF to Dexamethasone Implant in Case of Poor Anatomical Response in Naïve Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion;Seminars in Ophthalmology;2024-01-28

3. Venöse retinale Gefäßverschlüsse;Springer Reference Medizin;2024

4. Branch retinal vein occlusion;Retinal and Choroidal Vascular Diseases of the Eye;2024

5. Central retinal vein occlusion;Retinal and Choroidal Vascular Diseases of the Eye;2024